Uncategorized
Achromatopsia – Pipeline Review, H1 2016 Featuring Amgen & Applied Genetic Technologies Corporation – Research and Markets
DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Achromatopsia - Pipeline Review, H1 2016" report to their offering. This report provides comprehensive information on the therapeutic development for Achromatopsia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews ke
